Direct monitoring pressure overload predicts cardiac hypertrophy in mice

Physiological Measurement

Volumn 28, Issue 11, 2007, Pages 1329-1339

  Duan, Sheng Zhong ^a   Ivashchenko, Christine Y ^a   Whitesall, Steven E ^a   D'Alecy, Louis G ^a,b   Mortensen, Richard M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Cardiac gene expression; Cardiac hypertrophy; Fibrosis; Pressure overload

Indexed keywords

BLOOD PRESSURE; GENE EXPRESSION; HEMODYNAMICS; MAMMALS; PATHOLOGY;

CARDIAC GENE EXPRESSION; CARDIAC GENES; CARDIAC HYPERTROPHY; CLASSICAL MODELING; DIRECT MONITORING; FIBROSE; GENES EXPRESSION; HAEMODYNAMICS; PRESSURE-OVERLOAD; SYSTOLIC PRESSURE;

HEART;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; GENE EXPRESSION; HEART HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART RATE; HEART SIZE; HEART VENTRICLE OVERLOAD; HEMODYNAMIC PARAMETERS; HISTOLOGY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TELEMETRY;

MURINAE; MUS;

EID: 35848940518     PISSN: 09673334     EISSN: 13616579     Source Type: Journal    
DOI: 10.1088/0967-3334/28/11/001     Document Type: Article

References (29)

1. Alexander N 1953 Effect of constriction of the abdominal aorta on femoral pulse and mean pressure in rabbits Am. J. Physiol. 174 179-84
2. Asakawa M, Takano H, Nagai T, Uozumi H, Hasegawa H, Kubota N, Saito T, Masuda Y, Kadowaki T and Komuro I 2002 Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo Circulation 105 1240-6
3. Atkins K B, Northcott C A, Watts S W and Brosius F C 2005 Effects of PPAR-gamma ligands on vascular smooth muscle marker expression in hypertensive and normal arteries Am. J. Physiol. Heart Circ. Physiol. 288 H235-43
4. Boluyt M O, O'Neill L, Meredith A L, Bing O H, Brooks W W, Conrad C H, Crow M T and Lakatta E G 1994 Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Marked upregulation of genes encoding extra cellular matrix components Circ. Res. 75 23-32
5. Brede M, Wiesmann F, Jahns R, Hadamek K, Arnolt C, Neubauer S, Lohse M J and Hein L 2002 Feedback inhibition of catecholamine release by two different alpha2-adrenoceptor subtypes prevents progression of heart failure Circulation 106 2491-6
6. De Acetis M et al 2005 Cardiac over expression of melusin protects from dilated cardiomyopathy due to long-standing pressure overload Circ. Res. 96 1087-94
7. De Windt L J et al 2001 Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo Proc. Natl. Acad. Sci. USA 98 3322-7
8. Diep Q N, El Mabrouk M, Cohn J S, Endemann D, Amiri F, Virdis A, Neves M F and Schiffrin E L 2002 Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma Circulation 105 2296-302
9. Duan S Z, Ivashchenko C Y, Russell M W, Milstone D S and Mortensen R M 2005 Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-gamma both induce cardiac hypertrophy in mice Circ. Res. 97 372-9
10. Esposito G, Rapacciuolo A, Naga Prasad S V, Takaoka H, Thomas S A, Koch W J and Rockman H A 2002 Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress Circulation 105 85-92
11. Heling A et al 2000 Increased expression of cytoskeletal, linkage, and extra cellular proteins in failing human myocardium Circ. Res. 86 846-53
12. Hoshijima M and Chien K R 2002 Mixed signals in heart failure: cancer rules J. Clin. Invest. 109 849-55
13. Kuwahara F, Kai H, Tokuda K, Kai M, Takeshita A, Egashira K and Imaizumi T 2002 Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats Circulation 106 130-5
14. Kuwahara F, Kai H, Tokuda K, Takeya M, Takeshita A, Egashira K and Imaizumi T 2004 Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation? Hypertension 43 739-45
15. Lekakis J P et al 2004 Cardiac hypertrophy in hypertension: relation to 24-h blood pressure profile and arterial stiffness Int. J. Cardiol. 97 29-33
16. Leon L R, Walker L D, DuBose D A and Stephenson L A 2004 Biotelemetry transmitter implantation in rodents: impact on growth and circadian rhythms Am. J. Physiol. Regul. Integr. Comp. Physiol. 286 R967-74
17. Liao Y et al 2004 Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice Circulation 110 692-9
18. Libhaber E N, Norton G R, Libhaber C D, Candy G P, Woodiwiss A J, Sliwa K, Essop M R and Sareli P 2005 Change in blood pressure predicts regression of cardiac hypertrophy in patients of African ancestry receiving agents influencing the renin-angiotensin system J. Hum. Hypertens. 19 659-61
19. McMullen J R, Shioi T, Zhang L, Tarnavski O, Sherwood M C, Kang P M and Izumo S 2003 Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy Proc. Natl. Acad. Sci. USA 100 12355-60
20. Nicoletti A and Michel J B 1999 Cardiac fibrosis and inflammation: interaction with hemodynamic and hormonal factors Cardiovasc. Res. 41 532-43
21. Nishida K et al 2004 p38 alpha mitogen-activated protein kinase plays a critical role in cardiomyocyte survival but not in cardiac hypertrophic growth in response to pressure overload Mol. Cell Biol. 24 10611-20
22. Ogata T, Miyauchi T, Sakai S, Takanashi M, Irukayama-Tomobe Y and Yamaguchi I 2004 Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway J. Am. Coll. Cardiol. 43 1481-8
23. Rockman H A, Ross R S, Harris A N, Knowlton K U, Steinhelper M E, Field L J, Ross J Jr and Chien K R 1991 Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy Proc. Natl. Acad. Sci. USA 88 8277-81
24. Schoenfeld J R, Vasser M, Jhurani P, Ng P, Hunter J J, Ross J Jr, Chien K R and Lowe D G 1998 Distinct molecular phenotypes in murine cardiac muscle development, growth, and hypertrophy J. Mol. Cell. Cardiol. 30 2269-80
25. Takimoto E et al 2005 Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load J. Clin. Invest. 115 1221-31
26. Wagner R A, Tabibiazar R, Powers J, Bernstein D and Quertermous T 2004 Genome-wide expression profiling of a cardiac pressure overload model identifies major metabolic and signaling pathway responses J. Mol. Cell Cardiol. 37 1159-70
27. Wettschureck N, Rutten H, Zywietz A, Gehring D, Wilkie T M, Chen J, Chien K R and Offermanns S 2001 Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Galphaq/Galpha11 in cardiomyocytes Nat. Med. 7 1236-40
28. Whitesall S E, Hoff J B, Vollmer A P and D'Alecy L G 2004 Comparison of simultaneous measurement of mouse systolic arterial blood pressure by radiotelemetry and tail-cuff methods Am. J. Physiol. Heart Circ. Physiol. 286 H2408-15
29. Young W G Jr, Sealy W C and Harris J S 1950 Effects of chronic constriction of the thoracic aorta upon renal dynamics Surg. Forum 92 200-5